Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

74.39
+4.286.10%
Post-market: 74.820.4300+0.58%19:59 EDT
Volume:2.91M
Turnover:215.71M
Market Cap:9.69B
PE:-126.43
High:75.61
Open:70.13
Low:70.11
Close:70.11
52wk High:75.61
52wk Low:11.16
Shares:130.29M
Float Shares:118.00M
Volume Ratio:1.05
T/O Rate:2.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5884
EPS(LYR):-0.3490
ROE:-9.40%
ROA:-5.05%
PB:11.74
PE(LYR):-213.12

Loading ...

10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences

THOMSON REUTERS
·
Aug 29

10x Genomics - to Seek Enhanced Damages and Permanent Injunction Against Parse in U.S.

THOMSON REUTERS
·
Aug 29

10x Genomics - Jury Awards Co over $4.80 Mln in Damages for Infringing Sales Feb 2021-June 30, 2026

THOMSON REUTERS
·
Aug 29

Movement Alert|10x Genomics, Inc. Falls 5.4% in Regular Trading, Executive Share Reduction Plan and Sector-Wide Weakness Weigh on Shares

Market Focus
·
Aug 29

10x Genomics Director Shehnaaz Suliman Disposes of USD 140,916.11 in Common Shares

Reuters
·
Aug 27

10x Genomics (TXG) Could Be 31% Above Fair Value After Its Sharp Rally

Simply Wall St.
·
Aug 27

10x Genomics (TXG) Stock Looks Above Fair Value After Atera Optimism

Simply Wall St.
·
Aug 26

Movement Alert|10x Genomics, Inc. Falls 5.28% in Regular Trading, Trading at $62.645

Market Focus
·
Aug 24

Movement Alert|10x Genomics, Inc. Rises 5.33% in Regular Trading, Trading at $60.53

Market Focus
·
Aug 19

10x Genomics (TXG) Stock Looks Fully Priced As Atera Demand Lifts Guidance

Simply Wall St.
·
Aug 18

10x Genomics Director Sarah A. Teichmann Disposes of USD 433,106 in Common Shares

Reuters
·
Aug 18

10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares Worth $1.15 Million

Reuters
·
Aug 14

10x Genomics is Maintained at Overweight by Stephens & Co.

Dow Jones
·
Aug 13

10x Genomics (TXG) Gets a Buy from Stephens

TIPRANKS
·
Aug 12

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12

10x Genomics, Inc. : Stephens Raises Target Price to $65 from $50

THOMSON REUTERS
·
Aug 12

Movement Alert|10x Genomics, Inc. Rises 5.09% in Regular Trading, Q2 Earnings Beat and Raised Full-Year Guidance Continue to Lift Shares

Market Focus
·
Aug 10

10x Genomics Inc : Canaccord Genuity Raises Target Price to $60 from $50

THOMSON REUTERS
·
Aug 10

10x Genomics price target raised to $47 from $42 at Piper Sandler

TIPRANKS
·
Aug 10

10x Genomics (TXG) Stock Rally Leans On Margin Gains And Cash

Simply Wall St.
·
Aug 08